Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 (2024)
- Authors:
- Ferreira, Rafael R.
- Martins, Ronaldo B.
- Pires, Isabela Batista
- Marques, Bruno Lemes
- Costa, Karla C.M.
- Lirio, Pedro Henrique Cassario
- Scomparin, Davi Silveira
- Scarante, Franciele Franco
- Batah, Sabrina Setembre
- Hallak, Jaime Eduardo Cecilio
- Crippa, José Alexandre de Souza
- Rodrigues, Livia C. M.
- Tostes, Rita de Cássia Aleixo
- Fabro, Alexandre Todorovic
- Arruda, Eurico
- Campos, Alline Cristina de
- USP affiliated authors: HALLAK, JAIME EDUARDO CECILIO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; PASSAGLIA, RITA DE CASSIA ALEIXO TOSTES - FMRP ; FABRO, ALEXANDRE TODOROVIC - FMRP ; ARRUDA NETO, EURICO DE - FMRP ; CAMPOS, ALLINE CRISTINA DE - FMRP ; MARQUES, BRUNO LEMES - FMRP ; LIRIO, PEDRO HENRIQUE CASSARO - FMRP ; SCOMPARIN, DAVI SILVEIRA - FMRP ; BATAH, SABRINA SETEMBRE - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.bbih.2024.100855
- Subjects: COVID-19; DOENÇAS CARDIOVASCULARES; NEFROPATIAS; INFLAÇÃO
- Keywords: SARS-CoV-2; Severe COVID-19; Neuroinflammation; Cardiovascular disease; BDNF; Kidney disease
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Philadelphia
- Date published: 2024
- Source:
- Título: Brain, Behavior, & Immunity - Health
- ISSN: 2666-3546
- Volume/Número/Paginação/Ano: v. 41, art. 100855, 2024
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc-nd
-
ABNT
FERREIRA, Rafael R. et al. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, v. 41, 2024Tradução . . Disponível em: https://doi.org/10.1016/j.bbih.2024.100855. Acesso em: 28 dez. 2025. -
APA
Ferreira, R. R., Martins, R. B., Pires, I. B., Marques, B. L., Costa, K. C. M., Lirio, P. H. C., et al. (2024). Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19. Brain, Behavior, & Immunity - Health, 41. doi:10.1016/j.bbih.2024.100855 -
NLM
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855 -
Vancouver
Ferreira RR, Martins RB, Pires IB, Marques BL, Costa KCM, Lirio PHC, Scomparin DS, Scarante FF, Batah SS, Hallak JEC, Crippa JA de S, Rodrigues LCM, Tostes R de CA, Fabro AT, Arruda E, Campos AC de. Cardiovascular and kidney diseases are positively associated with neuroinflammation and reduced brain-derived neurotrophic factor in patients with severe COVID-19 [Internet]. Brain, Behavior, & Immunity - Health. 2024 ; 41[citado 2025 dez. 28 ] Available from: https://doi.org/10.1016/j.bbih.2024.100855 - A rat model of neurocysticercosis-induced hydrocephalus: chronic progressive hydrocephalus with mild clinical impairment
- Pulmonary pathology of ARDS in COVID-19: a pathological review for clinicians
- Production and evaluation of leukocyte- and thrombocyte-rich fibrin membranes in birds
- Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
- Neuroprotective effects of cannabidiol in human neural cell lines infected with SARS-CoV-2
- The therapeutic potential of harmine and ayahuasca in depression: evidence from exploratory animal and human studies
- Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine
- Postural balance in patients with social anxiety disorder
- Short-term treatment of Catatonia with amantadine in schizophrenia and schizoaffective disorder. [Carta]
- New treatment options for panic disorder: clinical trials from 2000 to 2010
Informações sobre o DOI: 10.1016/j.bbih.2024.100855 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003254485.pdf | Direct link | |
|
003254485.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
